Enhanced and impaired attentional performance after infusion of D1 dopaminergic receptor agents into rat prefrontal cortex

Journal of Neuroscience

Volumn 20, Issue 3, 2000, Pages 1208-1215

  Granon, Sylvie ^a,c   Passetti, Filippo ^a   Thomas, Kerrie L ^a   Dalley, Jeffrey W ^a   Everitt, Barry J ^a   Robbins, Trevor W ^a,b  

^a UK   (United Kingdom)

^b Dept of Experimental Psychology ^*  (United Kingdom)

^c INSTITUT PASTEUR   (France)

Author keywords

Attention; Cognition; D1 receptor; D2 receptor; Dopamine; Prefrontal cortex; SKF 38393, SCH 23390; Sulpiride

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; SULPIRIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATTENTION DEFICIT DISORDER; CONTROLLED STUDY; DRUG ANTAGONISM; MALE; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; REACTION TIME;

EID: 0034143246     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.20-03-01208.2000     Document Type: Article

References (42)

1. Arnsten AFT (1997) Catecholaminergic regulation of the prefrontal cortex. J Psychopharmacol 11:151-162.
2. Arnsten AFT (1998) Catecholamine modulation of prefrontal cortical cognitive function. Trends Cognit Sci 2:436-447.
3. Arnsten AFT, Cai JX, Murphy BL, Goldman-Rakic PS (1994) Dopamine D1 receptor mechanisms in the cognitive performance of young adult and aged monkeys. Psychopharmacology (Berl) 116:143-151.
4. Baunez C, Robbins TW (1999) Effects of dopamine depletion of the dorsal striatum and further interaction with subthalamic nucleus lesions in an attentional task in the rat. Neuroscience 92:1343-1356.
5. Bischoff S, Heinrich M, Krauss J, Sills MA, Williams M, Vassout A (1988) Interaction of the D1 receptor antagonist SCH 23390 with the central 5-HT system: radioligand binding studies, measurements of biochemical parameters and effects on L-5-HTP syndrome. J Recept Res 8:107-120.
6. Briggs CA, Pollock NJ, Frail DJ, Paxson CL, Ralowski RF, Kang CH, Kebabian JW (1991) Activation of the 5-HT1c receptor expressed in Xenopus oocytes by the benzazepines SCH 23390 and SKF 38393. Br J Pharmacol 104:1038-1044.
7. Brozoski T, Brown RM, Rosvold HE, Goldman PS (1979) Cognitive deficit caused by regional depletion of dopamine in prefrontal cortex of rhesus monkey. Science 205:929-931.
8. Carli M, Robbins TW, Evenden JL, Everitt BJ (1983) Effects of lesions to ascending noradrenergic neurones on performance of a 5-choice serial reaction task in rats: implications for theories of dorsal noradrenergic bundle function based on selective attention and arousal. Behav Brain Res 9:361-380.
9. Cole BJ, Robbins TW (1989) Effects of 6-hydroxydopamine lesions of the nucleus accumbens septi on performance of a 5-choice serial reaction time task in rats: implications for theories of selective attention and arousal. Behav Brain Res 33:165-179.
10. Collins P, Roberts AC, Dias R, Everitt BJ, Robbins TW (1998) Perseveration and strategy in a novel spatial self-ordered sequencing task for non-human primates: effects of excitotoxic lesions and dopamine depletions of the prefrontal cortex. J Cognit Neurosci 10:332-354.
11. Duvauchelle CL, Fleming SM, Kornetsky C (1998) Prefrontal cortex infusions of SCH 23390 cause immediate and delayed effects on ventral tegmental area stimulation reward. Brain Res 811:57-62.
12. Gong L, Kostrzewa RM, Fuller RW, Perry KW (1992) Supersensitization of the oral response to SKF 38393 in neonatal 6-OHDA-lesioned rats is mediated through a serotonin system. J Pharmacol Exp Ther 261:1000-1007.
13. Granon S, Poucet B, Thinusblanc C, Changeux JP, Vidai C (1995) Nicotinic and muscarinic receptors in the rat prefrontal cortex-differential roles in working-memory, response selection and effortful processing. Psychopharmacology 119:139-144.
14. Kimberg DY, D'Esposito M, Farah MJ (1997) Effects of bromocriptine on human subjects depends on working memory capacity. NeuroReport 8:3581-3585.
15. Lange K, Robbins TW, Marsden CD, James M, Owen A, Paul GM (1992) L-Dopa withdrawal selectively impairs performance in tests of frontal lobe function in Parkinson's disease. Psychopharmacology 107:394-404.
16. McDowell S, Whyte J, D'Esposito M (1998) Differential effect of a dopaminergic agonist on prefrontal function in traumatic brain injury patients. Brain 121:1155-1164.
17. 2C receptors tonically inhibit dopamine (DA) and noradrenaline (NA), but not 5-HT, release in the frontal cortex in vivo. Neuropharmacology 37:953-955.
18. Muir JL, Robbins TW, Everitt BJ (1994) AMPA-induced lesions of the basal forebrain: a significant role for the cortical cholinergic system in attentional function. J Neurosci 14:2313-2326.
19. Muir JL, Everitt BJ, Robbins TW (1996) The cerebral cortex of the rat and visual attentional function: dissociable effects of mediofrontal, cingulate, anterior dorsolateral and parietal cortex lesions on a five choice serial reaction time task in rats. Cereb Cortex 6:470-481.
20. Muller U, von Cramon DY, Pollmann S (1998) D1 - versus D2 - receptor modulation of visuospatial working memory in humans. J Neurosci 18:2720-2728.
21. Murphy BL, Arnsten AFT, Goldman-Rakic PS, Roth RH (1996a) Increased dopamine turnover in the prefrontal cortex impairs spatial working memory performance in rats and monkeys. Proc Natl Acad Sci USA 93:1325-1329.
22. Murphy BL, Arnsten AFT, Jentsch JD, Roth RH (1996b) Dopamine and spatial working memory in rats and monkeys: pharmacological reversal of stress-induced impairment. J Neurosci 16:7768-7775.
23. Ohlstein EH, Berkowitz BA (1985) SCH 23390 and SKF 83566 are antagonists at vascular dopamine and serotonin receptors. Eur J Pharmacol 108:205-208.
24. Paxinos G, Watson C (1982) The rat brain in stereotaxic coordinates. Australia: Academic.
25. Pehek EA (1996) Local infusion of the serotonin antagonists ritanserin or ICS 205,930 increases in vivo dopamine release in the rat medial prefrontal cortex. Synapse 24:12-18.
26. Pehek EA, Bi Y (1997) Ritanserin administration potentiates amphetamine-stimulated dopamine release in the rat prefrontal cortex. Prog Neuropsychopharmacol Biol Psychiatry 21:671-682.
27. Plech A, Brus R, Kalbfleisch, Kostrzewa RM (1995) Enhanced oral activity to intrastriatal SKF 38393 and mCPP are attenuated by intrastriatal mianserin in neonatal 6-OHDA-lesioned rats. Psychopharmacology 119:466-473.
28. Robbins TW (1985) Neuropsychological evaluation of higher cognitive function in animals and man: can psychopharmacology contribute to neuropsychology? In: Psychopharmacology: recent advances and future prospects (Iversen SD, ed) pp 155-169. Oxford: Oxford UP.
29. Robbins TW (1998) The psychopharmacology and neuropsychology of attention in experimental animals. In: The attentive brain (Parasuraman R, ed) pp 189-200, Cambridge, MA: MIT.
30. Robbins TW, Everitt BJ (1995) Arousal systems and attention. In: The cognitive neuroscienccs (Gazzaniga M, ed), pp 703-720. Cambridge, MA: MIT.
31. Robbins TW, Roberts AC, Owen AM, Sahakian BJ, Everitt BJ, Wilkinson LS, Muir JL, De Salvia M, Tovee M (1993) Monoaminergic-dependent cognitive functions of the prefrontal cortex in monkey and man. In: Prefrontal cortex (Christen Y, ed), pp 95-111. Heidelberg: Springer.
32. Robbins TW, Granon S, Muir JL, Durantou F, Harrison A, Everitt BJ (1998) Neural systems underlying arousal and attention. In: Cocaine: effects on the developing brain (Harvey JA, Kosofsky BE, eds). Ann NY Acad Sci 846:222-237.
33. Roberts AC, De Salvia MA, Wilkinson LS, Collins P, Muir JL, Everitt BJ, Robbins TW (1994) 5-hydroxydopamine lesions of the prefrontal cortex in monkeys enhance performance on an analogue of the Wisconsin Card Sorting test: possible interactions with subcortical dopamine. J Neurosci 14:2531-2544.
34. Sahakian BJ, Sarna GS, Kantamaneni BD, Jackson A, Hutson PH, Curzon G (1985) Association between learning and cortical catecholamines in non-drug-treated rats. Psychopharmacology 86:339-343.
35. Sawaguchi T, Goldman-Rakic PS (1991) D1 dopamine receptors in prefrontal cortex: involvement in working memory. Science 251:947-950.
36. 2A receptor antagonist, MDL 100,907, increases dopamine efflux in the prefrontal cortex of the rat. Eur J Pharmacol 273:273-279.
37. Seamans JK, Floresco SB, Phillips AG (1998) D1 receptor modulation of hippocampal-prefrontal cortical circuits integrating spatial memory with executive control functions in the rat. J Neurosci 18:1613-1621.
38. Simon H (1981) Dopaminergic A10 neurons and the frontal system. J Physiol (Paris) 77:81-95.
39. Vezina P, Blanc G, Glowinski J, Tassin J-P (1994) Blockade of D-1 dopamine receptors in the medial prefrontal cortex produces delayed effects on pre- and postsynaptic indices of dopamine function in the nucleus accumbens. Synapse 16:104-112.
40. Williams GV, Goldman-Rakic (1995) Modulation of memory fields by dopamine D1 receptors in prefrontal cortex. Nature 376:572-575.
41. Yang CR, Seamans JK (1996) Dopamine D1 receptor actions in layers V-V1 rat prefrontal cortex neurons in vitro: modulation of dendritic-somatic signal integration. J Neurosci 16:1922-1935.
42. Zahrt J, Taylor JR, Mathew RG, Arnsten AFT (1997) Supranormal stimulation of D1 dopamine receptors in the rodent prefrontal cortex impairs working memory performance. J Neurosci 17:8528-8535.